Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
NCT07107126
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Interventions
DRUG:
RPT1G
Sponsor
Remedy Plan, Inc.